Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
Actual shortage: | 236 (8%) | |
Anticipated shortage: | 18 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
29 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2024-04-26 | 2024-04-26 | 226348 |
APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2017-06-28 | 2017-10-26 | 14183 |
APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2018-07-04 | 2018-08-22 | 54184 |
APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2018-08-27 | 2021-12-10 | 59299 |
APO-MEDROXY TABLETS | 5MG | TABLET | Resolved | 2021-10-01 | 2022-01-31 | 146508 |
APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2021-10-15 | 2022-01-31 | 147299 |
APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2023-04-14 | 2024-03-22 | 189662 |
APO-MEDROXY TABLETS | 5MG | TABLET | Resolved | 2023-04-14 | 2024-03-22 | 189665 |
APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2023-09-07 | 2023-12-01 | 203822 |
APO-MEDROXY TABLETS | 5MG | TABLET | Resolved | 2023-09-15 | 2023-12-01 | 204414 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2017-04-07 | 2017-05-18 | 5997 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2017-06-28 | 2017-10-27 | 14186 |
APO-MEDROXY | 100MG | TABLET | Resolved | 2017-10-03 | 2017-11-02 | 24268 |
APO-MEDROXY | 100MG | TABLET | Resolved | 2020-07-29 | 2020-08-05 | 121331 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2020-09-09 | 2020-12-07 | 123944 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2021-05-28 | 2021-08-03 | 140069 |
APO-MEDROXY | 100MG | TABLET | Resolved | 2021-08-27 | 2022-01-31 | 144662 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2021-10-15 | 2022-01-31 | 147302 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2022-07-22 | 2022-08-12 | 165326 |
APO-MEDROXY | 10MG | TABLET | Resolved | 2023-01-13 | 2024-03-22 | 181101 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
APO-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60708 |
APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119950 |